Researchers looked at heart muscle function in 1,086 young people living with Type 1 Diabetes. They compared these results to a group of healthy individuals using a specific imaging technique called speckle-tracking. This method measures how the heart muscle contracts and moves over time.
The study found that the heart muscle movement, specifically measured as 2D LV GLS, was significantly impaired in the group with Type 1 Diabetes. However, other measurements, such as 3D LV GLS, did not show a significant difference between the two groups. Factors like the age of the patient, how long they had lived with diabetes, and their blood sugar levels did not change the results.
Because the evidence is currently of low certainty and the data was varied, these findings are not yet ready to change standard medical practice. However, this type of imaging could eventually help doctors better identify heart risks in young patients with Type 1 Diabetes. You should speak with a healthcare provider to discuss how these findings relate to your specific care.
Common questions
What did the study find about heart health in children with Type 1 Diabetes?
The study found that a specific measurement of heart muscle movement, known as 2D LV GLS, was significantly impaired in youth with Type 1 Diabetes compared to healthy controls. This finding suggests that certain heart functions are affected by the condition, though the evidence is currently of low certainty.
Did factors like age or blood sugar levels affect the results?
The researchers performed a meta-regression to see if age, the duration of diabetes, or HbA1c levels influenced the results. They found no associations between these factors and the heart muscle measurements, meaning the impairment was observed regardless of those specific variables.
Is this finding enough to change how doctors treat Type 1 Diabetes?
The evidence is currently not strong enough to change standard medical practices. While the imaging tool could be useful for identifying heart risks in the future, patients should continue to follow their current treatment plans and talk to their doctors about new findings.
